| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amarin Corp Plc\uk (AMRN) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. AMRN is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 80.7K | $1.29M | - | |
| COO | 9.7K | $155.7K | - | |
| CFO | 6.4K | $103.2K | - | |
| VP | 3.7K | $59.1K | - | |
| VP | 2.2K | $35.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2019 | Kennedy Joseph T | General Counsel | Sale+OE | 27,231 | $20.72 | $564,171.86 | -46.6% | |
| Feb 22, 2019 | Zakrzewski Joseph S55 | Director | Sale+OE | 180,625 | $19.90 | $3,594,437.50 | -68.1% | |
| Feb 22, 2019 | Van Heek G Jan | Director | Sale+OE | 203,382 | $20.02 | $4,071,422.91 | -93.5% | |
| Feb 22, 2019 | Kalb Michael Wayne | SVP And CFO | Sale+OE | 50,000 | $18.97 | $948,500.00 | -70.9% | |
| Feb 22, 2019 | Peterson Kristine | Director | Sale+OE | 163,500 | $20.02 | $3,274,038.45 | -100% | |
| Feb 15, 2019 | Kalb Michael Wayne | SVP And CFO | Sell | 25,000 | $17.58 | $439,525.00 | -54.9% | |
| Feb 1, 2019 | Ketchum Steven B | Chief Scientific Officer | Sale+OE | 37,530 | $17.17 | $644,372.89 | -5.1% | |
| Jan 31, 2019 | Kennedy Joseph T | General Counsel | Sale+OE | 42,624 | $17.49 | $745,468.19 | -57.7% | |
| Jan 24, 2019 | Kennedy Joseph T | General Counsel | Sale+OE | 1,040,194 | $17.77 | $18,487,911.33 | -70.5% | |
| Jan 11, 2019 | Kennedy Joseph T | General Counsel | Sale+OE | 3,173 | $18.92 | $60,033.16 | -1.4% |